D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 56 Citations 12,512 146 World Ranking 2729 National Ranking 67

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Internal medicine
  • Virus

Colin Kovacs mainly focuses on Immunology, Cytotoxic T cell, Virology, CD8 and Viral load. His Immunology study frequently links to related topics such as Acquired immunodeficiency syndrome. His study explores the link between Cytotoxic T cell and topics such as Immune system that cross with problems in Cytokine.

His work deals with themes such as NK-92 and Provirus, which intersect with Virology. His CD8 study incorporates themes from Acquired immune system and Ex vivo. His Viral load research integrates issues from Pharmacokinetics, Regimen, Tolerability, Placebo and Vitamin C.

His most cited work include:

  • Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. (1210 citations)
  • Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection (580 citations)
  • Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. (403 citations)

What are the main themes of his work throughout his whole career to date?

Colin Kovacs spends much of his time researching Immunology, Virology, Viral load, Cytotoxic T cell and Immune system. His research in T cell, Interleukin 21, Lentivirus, Viral disease and Viral replication are components of Immunology. The concepts of his Virology study are interwoven with issues in Peripheral blood mononuclear cell, Semen and Antibody.

The Viral load study combines topics in areas such as Hiv infected and Regimen, Internal medicine. His research investigates the connection between Cytotoxic T cell and topics such as CD8 that intersect with problems in T lymphocyte. His studies in Immune system integrate themes in fields like Cancer research, Cytokine and Antigen.

He most often published in these fields:

  • Immunology (57.24%)
  • Virology (41.45%)
  • Viral load (28.95%)

What were the highlights of his more recent work (between 2015-2021)?

  • Virology (41.45%)
  • Immunology (57.24%)
  • Immune system (21.05%)

In recent papers he was focusing on the following fields of study:

Colin Kovacs mostly deals with Virology, Immunology, Immune system, Cytotoxic T cell and Viremia. His research in Virology tackles topics such as Proviral dna which are related to areas like Viral genetics. His research is interdisciplinary, bridging the disciplines of Internal medicine and Immunology.

His study on Humoral immunity is often connected to Cart as part of broader study in Immune system. His Cytotoxic T cell study also includes

  • CD8, which have a strong connection to T cell, Antigen presentation and Virus latency,
  • Cytokine secretion, which have a strong connection to Hepatitis C virus, Hepatitis C and Hepacivirus. His study in Viremia is interdisciplinary in nature, drawing from both Discontinuation, Regimen, Randomized controlled trial, Tetanus and In vivo.

Between 2015 and 2021, his most popular works were:

  • Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. (152 citations)
  • A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. (91 citations)
  • Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells (87 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Internal medicine
  • Gene

The scientist’s investigation covers issues in Immune system, Immunology, Cytotoxic T cell, Virology and CD8. His work carried out in the field of Immune system brings together such families of science as Raltegravir Potassium, Maraviroc, Inflammation, Viremia and Emtricitabine. His study in the field of T cell and Viral load also crosses realms of Metabolic syndrome.

The various areas that he examines in his Cytotoxic T cell study include Translation, Provirus, Antiretroviral therapy and splice. His Virology research incorporates themes from Downregulation and upregulation, Alternative splicing, Cytokine secretion, Antigen presentation and Immunotherapy. His research in CD8 intersects with topics in Virus latency, Virus and Ex vivo, In vitro.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Janet D Siliciano;Joleen Kajdas;Diana Finzi;Thomas C Quinn;Thomas C Quinn.
Nature Medicine (2003)

1834 Citations

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

R. Brad Jones;Lishomwa C Ndhlovu;Jason D. Barbour;Prameet M. Sheth.
Journal of Experimental Medicine (2008)

827 Citations

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Domenico Mavilio;Gabriella Lombardo;Janet Benjamin;Diana Kim.
Proceedings of the National Academy of Sciences of the United States of America (2005)

583 Citations

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

Martin Markowitz;Bach-Yen Nguyen;Eduardo Gotuzzo;Fernando Mendo.
Journal of Acquired Immune Deficiency Syndromes (2007)

578 Citations

Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.

Martin Markowitz;Javier O Morales-Ramirez;Bach-Yen Nguyen;Colin M Kovacs.
Journal of Acquired Immune Deficiency Syndromes (2006)

506 Citations

Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects.

Johane P. Allard;Elaheh Aghdassi;Jenny Chau;Carolyn Tam.
AIDS (1998)

375 Citations

Perforin Expression Directly Ex Vivo by HIV-Specific CD8 + T-Cells Is a Correlate of HIV Elite Control

Adam R. Hersperger;Florencia Pereyra;Martha Nason;Korey R. Demers.
PLOS Pathogens (2010)

375 Citations

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir

Tae Wook Chun;David C. Nickle;J. Shawn Justement;Danielle Large.
Journal of Clinical Investigation (2005)

325 Citations

Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

Susan Moir;Angela Malaspina;Oxana K. Pickeral;Eileen T. Donoghue.
Journal of Experimental Medicine (2004)

278 Citations

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.

Tae Wook Chun;J. Shawn Justement;Danielle Murray;Claire W. Hallahan.
AIDS (2010)

272 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Colin Kovacs

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 187

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 121

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 114

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 106

Nicolas Chomont

Nicolas Chomont

University of Montreal

Publications: 72

Jean-Pierre Routy

Jean-Pierre Routy

McGill University Health Centre

Publications: 72

David M. Margolis

David M. Margolis

University of North Carolina at Chapel Hill

Publications: 66

Janet D. Siliciano

Janet D. Siliciano

Johns Hopkins University School of Medicine

Publications: 58

Marcus Altfeld

Marcus Altfeld

Heinrich-Pette-Institute

Publications: 55

Guido Silvestri

Guido Silvestri

Emory University

Publications: 53

Mathias Lichterfeld

Mathias Lichterfeld

Brigham and Women's Hospital

Publications: 51

Rupert Kaul

Rupert Kaul

University of Toronto

Publications: 50

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 50

Javier Martinez-Picado

Javier Martinez-Picado

University of Vic

Publications: 49

John W. Mellors

John W. Mellors

University of Pittsburgh

Publications: 47

Christine Rouzioux

Christine Rouzioux

Necker-Enfants Malades Hospital

Publications: 44

Trending Scientists

Ruud H. Teunter

Ruud H. Teunter

University of Groningen

Domenico Saccà

Domenico Saccà

University of Calabria

Christophe Léger

Christophe Léger

Aix-Marseille University

Stéphane Bellemin-Laponnaz

Stéphane Bellemin-Laponnaz

University of Strasbourg

David Dye

David Dye

Imperial College London

John V. Pearson

John V. Pearson

QIMR Berghofer Medical Research Institute

Arild Folkvord

Arild Folkvord

University of Bergen

Mario A. Moscarello

Mario A. Moscarello

University of Toronto

Bernhard Ehlers

Bernhard Ehlers

Robert Koch Institute

Darren J. Moore

Darren J. Moore

École Polytechnique Fédérale de Lausanne

Marta Carballa

Marta Carballa

University of Santiago de Compostela

Jessica L. Tracy

Jessica L. Tracy

University of British Columbia

Viorica Marian

Viorica Marian

Northwestern University

Glenn D. Wilson

Glenn D. Wilson

King's College London

Yuhua Ruan

Yuhua Ruan

Chinese Center For Disease Control and Prevention

Pierre Kervella

Pierre Kervella

Université Paris Cité

Something went wrong. Please try again later.